Establishment Labs (ESTA) Competitors $41.81 +4.29 (+11.43%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ESTA vs. AVNS, EAR, INGN, IVC, AXNX, NVST, NARI, LIVN, TMDX, and ENOVShould you be buying Establishment Labs stock or one of its competitors? The main competitors of Establishment Labs include Avanos Medical (AVNS), Eargo (EAR), Inogen (INGN), Invacare (IVC), Axonics (AXNX), Envista (NVST), Inari Medical (NARI), LivaNova (LIVN), TransMedics Group (TMDX), and Enovis (ENOV). These companies are all part of the "medical" sector. Establishment Labs vs. Avanos Medical Eargo Inogen Invacare Axonics Envista Inari Medical LivaNova TransMedics Group Enovis Establishment Labs (NASDAQ:ESTA) and Avanos Medical (NYSE:AVNS) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, profitability, community ranking, valuation, institutional ownership, risk, earnings, media sentiment and analyst recommendations. Does the media refer more to ESTA or AVNS? In the previous week, Establishment Labs had 1 more articles in the media than Avanos Medical. MarketBeat recorded 2 mentions for Establishment Labs and 1 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.76 beat Establishment Labs' score of 0.56 indicating that Avanos Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Establishment Labs 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Avanos Medical 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has better earnings & valuation, ESTA or AVNS? Avanos Medical has higher revenue and earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than Avanos Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEstablishment Labs$165.15M7.09-$78.50M-$2.58-16.21Avanos Medical$673.30M1.22-$61.80M$0.3452.56 Does the MarketBeat Community believe in ESTA or AVNS? Establishment Labs received 30 more outperform votes than Avanos Medical when rated by MarketBeat users. Likewise, 61.70% of users gave Establishment Labs an outperform vote while only 55.84% of users gave Avanos Medical an outperform vote. CompanyUnderperformOutperformEstablishment LabsOutperform Votes11661.70% Underperform Votes7238.30% Avanos MedicalOutperform Votes8655.84% Underperform Votes6844.16% Is ESTA or AVNS more profitable? Avanos Medical has a net margin of 2.30% compared to Establishment Labs' net margin of -46.13%. Avanos Medical's return on equity of 4.70% beat Establishment Labs' return on equity.Company Net Margins Return on Equity Return on Assets Establishment Labs-46.13% -184.55% -24.81% Avanos Medical 2.30%4.70%3.46% Do analysts rate ESTA or AVNS? Establishment Labs presently has a consensus target price of $60.60, suggesting a potential upside of 44.94%. Given Establishment Labs' stronger consensus rating and higher possible upside, research analysts clearly believe Establishment Labs is more favorable than Avanos Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Establishment Labs 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80Avanos Medical 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more volatility and risk, ESTA or AVNS? Establishment Labs has a beta of 1.2, indicating that its stock price is 20% more volatile than the S&P 500. Comparatively, Avanos Medical has a beta of 0.92, indicating that its stock price is 8% less volatile than the S&P 500. Do institutionals & insiders have more ownership in ESTA or AVNS? 72.9% of Establishment Labs shares are held by institutional investors. Comparatively, 95.2% of Avanos Medical shares are held by institutional investors. 11.4% of Establishment Labs shares are held by insiders. Comparatively, 2.9% of Avanos Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummaryEstablishment Labs and Avanos Medical tied by winning 9 of the 18 factors compared between the two stocks. Ad WealthPressBreaking News: Tesla headed to $500…That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. Get Establishment Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for ESTA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ESTA vs. The Competition Export to ExcelMetricEstablishment LabsSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.17B$9.70B$5.06B$8.82BDividend YieldN/A1.10%5.18%4.07%P/E Ratio-16.2123.02126.3117.81Price / Sales7.6530.911,178.7474.57Price / CashN/A23.3733.8632.53Price / Book58.895.614.684.68Net Income-$78.50M$182.72M$119.54M$226.08M7 Day Performance11.46%38.40%-1.83%-1.04%1 Month Performance0.02%54.60%-3.60%1.04%1 Year Performance72.70%3.49%31.91%26.28% Establishment Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ESTAEstablishment Labs2.1311 of 5 stars$41.81+11.4%$60.60+44.9%+90.0%$1.05B$165.15M-16.21960High Trading VolumeAVNSAvanos Medical3.9871 of 5 stars$17.87+0.4%N/A-16.6%$818.03M$673.30M52.563,771Positive NewsEAREargoN/A$70.50flatN/AN/A$1.46B$41.11M-9.38243INGNInogen3.0472 of 5 stars$9.46-0.3%$7.00-26.0%+63.4%$226.04M$315.66M-4.20834IVCInvacareN/AN/AN/AN/A$20.01M$872.46M-0.243,000Analyst ForecastGap DownAXNXAxonics3.2587 of 5 stars$70.98flat$71.00+0.0%N/A$3.63B$366.38M-591.45610News CoverageNVSTEnvista3.6426 of 5 stars$20.37+0.5%$20.71+1.7%-14.3%$3.49B$2.57B-2.6212,800NARIInari Medical3.2625 of 5 stars$49.00-3.9%$58.89+20.2%-15.9%$2.98B$493.63M0.001,300Insider TradePositive NewsLIVNLivaNova4.1794 of 5 stars$50.05-2.6%$69.17+38.2%+6.8%$2.79B$1.15B119.172,900TMDXTransMedics Group4.4367 of 5 stars$77.20-6.9%$131.80+70.7%+10.5%$2.78B$241.62M82.13210Analyst ForecastGap DownENOVEnovis3.2254 of 5 stars$44.78-1.1%$67.00+49.6%-12.3%$2.53B$1.71B0.006,550 Related Companies and Tools Related Companies Avanos Medical Alternatives Eargo Alternatives Inogen Alternatives Invacare Alternatives Axonics Alternatives Envista Alternatives Inari Medical Alternatives LivaNova Alternatives TransMedics Group Alternatives Enovis Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ESTA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Establishment Labs Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Establishment Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
